Clinical Trials in Nashville

Showing 18261-18280 of 20,298 trials

A Study of NK012 in Patients With Relapsed Small Cell Lung Cancer

NCT00951613

The purpose of this study is to determine whether NK012 is safe and effective in the treatment of relapsed small cell lung cancer.

Small Cell Lung Cancer

Nippon Kayaku Co., Ltd.72 participantsStarted Jul 2009

Nashville, Tennessee, United States

COMPLETEDPhase 1< 1 mile

Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma

NCT00996957

For cancer cells to grow, they need to have nutrients supplied to them through blood vessels. The study drug, ACE-041, is designed to work by blocking the growth of those blood vessels and preventing cancer cells from growing. The purpose of this study is to establish safe dose levels of ACE-041 in patients with advanced solid tumors or relapsed/refractory multiple myeloma following multiple dose administration. This study will also evaluate if ACE-041 has an effect on tumors.

Advanced Solid TumorsMultiple Myeloma

Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA37 participantsStarted Oct 2009

Scottsdale, Arizona, United States • Durham, North Carolina, United States • Nashville, Tennessee, United States +1 more locations

COMPLETEDPhase 3< 1 mile

Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage

NCT00198510

The purpose of this study is to determine if intravitreal injection of Vitrase (ovine hyaluronidase) clears vitreous hemorrhage

Vitreous HemorrhageDiabetic Retinopathy

Bausch & Lomb Incorporated750 participantsStarted Nov 1998

Tucson, Arizona, United States • Beverly Hills, California, United States • Chula Vista, California, United States +70 more locations

A Study of NK012 in Patients With Relapsed Small Cell Lung Cancer

Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma

Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage

Find Trials by Condition in Nashville

Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPC

Standard vs High-Dose Trivalent Inactivated Flu Vaccine in Adult Hematopoetic Stem Cell Transplant (HSCT) Recipients

Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy

INFUSE® Bone Graft/ PEEK Interbody Spacer/ Anterior Cervical Plate Pivotal Clinical Trial

The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4

Evaluation of Vitrase as a Spreading Agent

Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis

Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid Arthritis

Efficacy of Esomeprazole in Patients With Frequent Heartburn

A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease

Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients

Ginkgo Biloba Prevention Trial in Older Individuals

A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte

Effect of Orlistat in Body Composition

Citalopram to Enhance Cognition in HD

Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis Vulgaris

CP-751,871 Treatment For Patients With Multiple Myeloma